Which is most likely abnormal in early mild neurocognitive disorder due to Alzheimer's disease: Romberg test, pronator drift, Mini-Mental State Examination (MMSE), or visual acuity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MMSE is Most Likely Abnormal in Early Mild Neurocognitive Disorder Due to Alzheimer's Disease

The Mini-Mental State Examination (MMSE) is the most likely to be abnormal among the options of Romberg test, pronator drift, MMSE, or visual acuity in early mild neurocognitive disorder due to Alzheimer's disease. 1

Rationale for MMSE Abnormality in Early Alzheimer's Disease

The MMSE is specifically designed to assess cognitive changes in patients with dementia and covers six key areas:

  1. Orientation
  2. Registration
  3. Attention and calculation
  4. Recall
  5. Language
  6. Ability to copy a figure

These cognitive domains are precisely those affected in early Alzheimer's disease, making the MMSE an appropriate tool for detecting early cognitive changes 1.

MMSE Performance in Mild Cognitive Impairment

  • A score of 23 or less on the MMSE suggests dementia, though scores vary by age and education 1
  • In early mild neurocognitive disorder due to Alzheimer's disease, the MMSE may show subtle deficits, particularly in:
    • Memory (recall section)
    • Orientation
    • Attention and calculation

Why Other Tests Are Less Likely to Be Abnormal

Romberg Test

  • The Romberg test assesses proprioception and cerebellar function
  • Early Alzheimer's disease primarily affects cognition, not balance or proprioception
  • Motor symptoms typically appear in later stages of the disease

Pronator Drift

  • Pronator drift evaluates upper motor neuron function
  • This test detects subtle weakness or pyramidal tract dysfunction
  • Not typically affected in early Alzheimer's disease which primarily involves cognitive domains

Visual Acuity

  • Visual acuity testing measures sharpness of vision
  • While visuospatial abilities may be affected in Alzheimer's disease, basic visual acuity remains intact in early stages
  • Visual problems in Alzheimer's disease are more related to visual processing and interpretation rather than acuity

Limitations of MMSE in Early Detection

It's important to note that while the MMSE is the most likely to be abnormal among the given options, it does have limitations:

  • The MMSE has limited sensitivity in detecting very mild dementia 1
  • It may not detect subtle cognitive changes in highly educated individuals due to cognitive reserve
  • More sensitive tests like the Montreal Cognitive Assessment (MoCA) have superior detection of mild cognitive impairment with a sensitivity of 90% compared to MMSE's lower sensitivity 2
  • The MMSE may show a score above the traditional cutoff of 23/30 in very early stages, despite subtle cognitive deficits being present 1

Clinical Implications

When evaluating a patient with suspected early mild neurocognitive disorder due to Alzheimer's disease:

  1. Administer the MMSE as part of the initial cognitive assessment
  2. Consider that subtle changes may be present even with scores above traditional cutoffs
  3. Pay particular attention to the recall and orientation sections, which are often affected first
  4. For more sensitive detection, consider supplementing with tests specifically designed for mild cognitive impairment, such as the MoCA 2
  5. Serial MMSE assessments over time (approximately every six months) can help track progression 1

In conclusion, among the four options presented, the MMSE is most likely to show abnormalities in early mild neurocognitive disorder due to Alzheimer's disease, though its limitations in detecting very mild impairment should be recognized.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cognitive Screening Tools

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.